FDA panel recommends Moderna’s mRNA flu shot for older adults
The vaccine was found to be about 27% more effective than the standard flu shot in a late-stage trial. The FDA and the CDC still must sign off on it before it’s available.
Ähnliche Seiten
FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy - The Boston Globe